MCK Q1 2026 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q1 2026 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$97.8B+23.4% YoY

Gross Profit

$3.3B3.4% margin

Operating Income

$1.0B1.1% margin

Net Income

$784M0.8% margin

EPS (Diluted)

$6.25

QoQ Revenue Growth

+7.7%

Cash Flow

Operating Cash Flow

-$918M

Free Cash Flow

-$1.0B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$81.3B

Total Liabilities

$82.2B

Stockholders' Equity

-$2.0B

Cash & Equivalents

$2.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$97.8B	$79.3B	+23.4%
Gross Profit	$3.3B	$3.0B	+10.9%
Operating Income	$1.0B	$1.1B	-2.4%
Net Income	$784M	$915M	-14.3%

Revenue Segments

U.S. Pharmaceutical Segment

$90.0B92%

International Segment

$3.7B4%

Medical-Surgical Solutions Segment

$2.7B3%

Prescription Technology Solutions

$1.4B1%